Drug Information

Drug General Information
Drug ID
D0Q2CR
Former ID
DNC014004
Drug Name
1-(1,3,4-Oxadiazol-2-yl)-7-phenylheptan-1-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529594]
Structure
Download
2D MOL

3D MOL
Formula
C15H18N2O2
Canonical SMILES
C1=CC=C(C=C1)CCCCCCC(=O)C2=NN=CO2
InChI
1S/C15H18N2O2/c18-14(15-17-16-12-19-15)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2
InChIKey
SRGOKBDAYNCSOV-UHFFFAOYSA-N
PubChem Compound ID
24950841
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529594]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529594J Med Chem. 2008 Aug 14;51(15):4392-403. Epub 2008 Jul 16.Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.
Ref 529594J Med Chem. 2008 Aug 14;51(15):4392-403. Epub 2008 Jul 16.Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.